MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
INSERM U 1168, VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France.
Allergy. 2017 Oct;72(10):1475-1484. doi: 10.1111/all.13177. Epub 2017 Jun 9.
Allergic rhinitis often impairs social life and performance. The aim of this cross-sectional study was to use cell phone data to assess the impact on work productivity of uncontrolled rhinitis assessed by visual analogue scale (VAS). A mobile phone app (Allergy Diary, Google Play Store and Apple App Store) collects data from daily visual analogue scales (VAS) for overall allergic symptoms (VAS-global measured), nasal (VAS-nasal), ocular (VAS-ocular) and asthma symptoms (VAS-asthma) as well as work (VAS-work). A combined nasal-ocular score is calculated. The Allergy Diary is available in 21 countries. The app includes the Work Productivity and Activity Impairment Allergic Specific Questionnaire (WPAI:AS) in six EU countries. All consecutive users who completed the VAS-work from 1 June to 31 October 2016 were included in the study. A total of 1136 users filled in 5818 days of VAS-work. Symptoms of allergic rhinitis were controlled (VAS-global <20) in approximately 60% of the days. In users with uncontrolled rhinitis, approximately 90% had some work impairment and over 50% had severe work impairment (VAS-work >50). There was a significant correlation between VAS-global calculated and VAS-work (Rho=0.83, P<0.00001, Spearman's rank test). In 144 users, there was a significant correlation between VAS-work and WPAI:AS (Rho=0.53, P<0.0001). This pilot study provides not only proof-of-concept data on the work impairment collected with the app but also data on the app itself, especially the distribution of responses for the VAS. This supports the interpretation that persons with rhinitis report both the presence and the absence of symptoms.
变应性鼻炎常影响社交生活和工作表现。本横断面研究旨在通过手机数据评估视觉模拟量表(VAS)评估的未控制变应性鼻炎对工作生产力的影响。一个手机应用程序(过敏日记,Google Play 商店和 Apple App Store)从日常视觉模拟量表(VAS)收集数据,用于整体过敏症状(VAS-global measured)、鼻(VAS-nasal)、眼(VAS-ocular)和哮喘症状(VAS-asthma)以及工作(VAS-work)。计算了联合鼻-眼评分。过敏日记在 21 个国家/地区可用。该应用程序在六个欧盟国家/地区包括工作生产力和活动障碍过敏特异性问卷(WPAI:AS)。从 2016 年 6 月 1 日至 10 月 31 日,完成 VAS-work 的所有连续用户均被纳入研究。共有 1136 名用户填写了 5818 天的 VAS-work。过敏性鼻炎症状得到控制(VAS-global <20)的天数约占 60%。在未得到控制的变应性鼻炎患者中,约 90%的人有一定程度的工作障碍,超过 50%的人有严重的工作障碍(VAS-work >50)。VAS-global 计算值与 VAS-work 之间存在显著相关性(Rho=0.83,P<0.00001,Spearman 秩检验)。在 144 名用户中,VAS-work 与 WPAI:AS 之间存在显著相关性(Rho=0.53,P<0.0001)。这项初步研究不仅提供了使用该应用程序收集的工作障碍的概念验证数据,还提供了有关该应用程序本身的数据,特别是 VAS 的响应分布。这支持了这样的解释,即患有鼻炎的人会报告症状的存在和不存在。